Results 131 to 140 of about 7,713 (194)

Expert Pathology for Gestational Trophoblastic Disease: Towards an International Multidisciplinary Team Meeting.

Gynecol Obstet Invest
Kaur B, Nadal A, Bartosch C, Rougemont AL.   +3 more
europepmc   +1 more source

From National to International Collaboration in Gestational Trophoblastic Disease: Hurdles and Possibilities.

Gynecol Obstet Invest
Golfier F, Seckl MJ.
europepmc   +1 more source

Measurement of Human Chorionic Gonadotrophin in Women with Gestational Trophoblastic Disease.

Gynecol Obstet Invest
McMahon LM, Joyce CM, Cuthill L, Mitchell H, Jabbar I, Sweep F, hCG working party of the EOTTD.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gestational trophoblastic disease

Lancet, The, 2010
Gestational trophoblastic disease encompasses a range of pregnancy-related disorders, consisting of the premalignant disorders of complete and partial hydatidiform mole, and the malignant disorders of invasive mole, choriocarcinoma, and the rare placental-site trophoblastic tumour.
Michael J Seckl, Neil J Sébire
exaly   +5 more sources

Gestational trophoblastic disease

Cancer, 1995
Gestational trophoblastic disease consists of a group of interrelated diseases, including molar pregnancy, placental site trophoblastic tumor, and choriocarcinoma.Advances in the diagnosis and management of gestational trophoblastic diseases over the past 5 years were reviewed.Molar pregnancy is now categorized as complete or partial on the basis of ...
Ross S Berkowitz, Donald P Goldstein
exaly   +3 more sources

Pharmacotherapy of gestational trophoblastic disease

Expert Opinion on Pharmacotherapy, 2003
Gestational trophoblastic neoplasms are the most responsive of all solid tumours to chemotherapy leading to an overall cure rate of > 90%. Non-metastatic disease (FIGO Stage I) and low-risk metastatic disease (FIGO Stages II and III; WHO score < 7) can be treated with single-agent methotrexate or actinomycin D protocols resulting in a survival rate ...
John R Lurain
exaly   +3 more sources